June 1, 1980European Heart Journal
Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure*
Why the study?
Does oral hydralazine improve hemodynamic parameters in patients with refractory congestive heart failure?
Population
20 consecutive patients with severe, refractory congestive heart failure
Design
Case_series
Follow-up
24 hours
Authors
Discussion
Loading...
Member takes
Implication
Variable hemodynamic response to hydralazine in refractory HF supports individualized monitoring; case-report data leave efficacy questions open.
Structured PICO
Does oral hydralazine improve hemodynamic parameters in patients with refractory congestive heart failure?
P
Population
20 consecutive patients with severe, refractory congestive heart failure
I
Intervention
Hydralazine 200 to 400 mg daily administered orally for 24 hours
O
Outcome
Change in hemodynamic parameters (cardiac index, mean blood pressure, and pulmonary wedge pressure) after 24 hourssurrogate
Oral hydralazine generally improves hemodynamics in severe heart failure, but individual responses vary significantly, suggesting a need for hemodynamic monitoring to evaluate responsiveness.
Cite This Study
LeJemtel et al. (1980) studied this question.